# Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients

> **NCT04087993** · PHASE3 · WITHDRAWN · sponsor: **Dr. Frank Behrens**

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Polyglucoferron
- **DRUG:** Ferric carboxymaltose
- **DRUG:** Ferrous Sulfate

## Key facts

- **NCT ID:** NCT04087993
- **Lead sponsor:** Dr. Frank Behrens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-15
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** difficult recruitment - redesign in discussion
- **Last updated:** 2024-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087993, "Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04087993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*